期刊
EUROSURVEILLANCE
卷 22, 期 7, 页码 2-10出版社
EUR CENTRE DIS PREVENTION & CONTROL
DOI: 10.2807/1560-7917.ES.2017.22.7.30464
关键词
-
资金
- European Union's Horizon 2020 research and innovation programme [634446]
- ECDC [ECDC/2014/026]
- Research Council of Lithuania [SEN-03/2015]
We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0-14, 15-64 and >= 65 year-olds, and 25.7% in the influenza vaccination target group. At hospital level, IVE was 2.5%, 7.9% and 2.4% among >= 65, 65-79 and >= 80 year-olds. As in previous seasons, we observed suboptimal IVE against influenza A(H3N2).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据